References
- Bateman ME, Strong AL, Gimble JM, et al. Concise review: using fat to fight disease: a systematic review of nonhomologous adipose-derived stromal/stem cell therapies. Stem Cells. 2018;36(9): 1311–12.
- Borakati A, Mafi R, Mafi P, et al. A systematic review and meta-analysis of clinical trials of mesenchymal stem cell therapy for cartilage repair. Curr Stem Cell Res Ther. 2018;13(3):215–225. Available from: http://www.eurekaselect.com/155605/article
- Zhao L, Chen S, Shi X, et al. A pooled analysis of mesenchymal stem cell-based therapy for liver disease. Stem Cell Res Ther. 2018;9(1):72. Available from: https://stemcellres.biomedcentral.com/articles/10.1186/s13287-018-0816-2
- Jeong H, Yim HW, Park H-J, et al. Mesenchymal stem cell therapy for ischemic heart disease: systematic review and meta-analysis. Int J Stem Cells. 2018;11(1):1–12. Available from: http://www.ijstemcell.com/journal/view.html?doi=10.15283/ijsc17061
- Lalu MM, Mazzarello S, Zlepnig J, et al. Safety and efficacy of adult stem cell therapy for acute myocardial infarction and ischemic heart failure (safecell heart): a systematic review and meta-analysis. Stem Cells Transl Med. 2018;7(12):857–866.
- Lalu MM, McIntyre L, Pugliese C, et al. Safety of cell therapy with mesenchymal stromal cells (safecell): a systematic review and meta-analysis of clinical trials. PLoS One. Beltrami AP, editor 2012;7(10):e47559. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23133515
- Lightner AL, Wang Z, Zubair AC, et al. A systematic review and meta-analysis of mesenchymal stem cell injections for the treatment of Perianal Crohn’s disease: progress made and future directions. Dis Colon Rectum. 2018;61(5):629–640. Available from: http://insights.ovid.com/crossref?an=00003453-201805000-00018
- Moll G, Ankrum JA, Kamhieh-Milz J, et al. Intravascular mesenchymal stromal/stem cell therapy product diversification: time for new clinical guidelines. Trends Mol Med. 2019;25(2):149–163. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1471491418302405
- Wahid FSA, Ismail NA, Wan Jamaludin WF, et al. Efficacy and safety of autologous cell-based therapy in patients with no-option critical limb ischaemia: a meta-analysis. Curr Stem Cell Res Ther. 2018;13(4):265–283. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29532760
- Xu P, Yang X. The efficacy and safety of mesenchymal stem cell transplantation for spinal cord injury patients: a meta-analysis and systematic review. Cell Transplant. 2019;28(1):36–46. Available from: http://journals.sagepub.com/doi/10.1177/0963689718808471
- Yim H, Jeong H, Cho Y, et al. Safety of mesenchymal stem cell therapy: a systematic review and meta-analysis. Cytotherapy. 2016;18(6):S132. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1465324916302821
- Caplan AI. Mesenchymal stem cells: time to change the name! Stem Cells Transl Med. 2017;66:1445–1451.
- Lener T, Gimona M, Aigner L, et al. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015;(4)30087. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4698466&tool=pmcentrez&rendertype=abstract
- Börger V, Bremer M, Ferrer-Tur R, et al. Mesenchymal stem/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents. Int J Mol Sci. 2017;18(7):1450. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28684664
- Reiner AT, Witwer KW, Bwm VB, et al. Concise review: developing best-practice models for the therapeutic use of extracellular vesicles. Stem Cells Transl Med. 2017;6:8.
- Dominici M, Le Blanc K, Mueller I, et al. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315–317. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16923606
- Lötvall J, Hill AF, Hochberg F, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the international society for extracellular vesicles. J Extracell Vesicles. 2014;3(1):26913.
- Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.
- Giebel B, Kordelas L, Börger V. Clinical potential of mesenchymal stem/stromal cell-derived extracellular vesicles. Stem Cell Investig. 2017;4(10): 84–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29167805
- Yeo RWY, Lim SK Exosomes and their therapeutic applications. In: Advances in Pharmaceutical Cell Therapy. WORLD SCIENTIFIC; 2015. p. 477–501. Available from: http://www.worldscientific.com/doi/abs/10.1142/9789814616799_0015
- Chen TS, Arslan F, Yin Y, et al. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med. 2011;9(1):47. Available from: http://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-9-47
- Harding C, Heuser J, Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol. 1983;97(2):329–339. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6309857
- Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983;33(3):967–978. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6307529
- Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013 Feb 20;200(4):373–383. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23420871
- Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015;25(6):364–372. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25683921
- Lai RC, Yeo RWY, Lim SK. Mesenchymal stem cell exosomes. Semin Cell Dev Biol. 2015;40:82–88. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1084952115000440
- Tkach M, Kowal J, Théry C. Why the need and how to approach the functional diversity of extracellular vesicles. Philos Trans R Soc Lond B Biol Sci. 2018;373(1737):20160479. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29158309
- Patel DB, Gray KM, Santharam Y, et al. Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell-derived extracellular vesicles. Available from Bioeng Transl Med. 2017;22:170–179.
- Robb KP, Fitzgerald JC, Barry F, et al. Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency. Cytotherapy. 2018; Available from: https://linkinghub.elsevier.com/retrieve/pii/S1465324918306753
- Antoni D, Burckel H, Josset E, et al. Three-dimensional cell culture: a breakthrough in vivo. Int J Mol Sci. 2015;16(12):5517–5527. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25768338
- Schallmoser K, Bartmann C, Rohde E, et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion. 2007;47(8):1436–1446. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17655588
- Hemeda H, Giebel B, Wagner W. Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells. Cytotherapy. 2014;16(2):170–180. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1465324913007779
- Doucet C, Ernou I, Zhang Y, et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol. 2005;205(2):228–236. Available from.
- Kordelas L, Rebmann V, Ludwig A-K, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014. Available from: http://www.nature.com/doifinder/10.1038/leu.2014.41
- Doeppner TR, Herz J, Görgens A, et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4(10):1131–1143. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26339036
- Henschler R, Gabriel C, Schallmoser K, et al. Human platelet lysate current standards and future developments. Transfusion. 2019. DOI:10.1111/trf.15174
- Thery C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2008 Jan 30;2006. Chapter 3: Unit3 22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18228490
- Kornilov R, Puhka M, Mannerström B, et al. Efficient ultrafiltration-based protocol to deplete extracellular vesicles from fetal bovine serum. J Extracell Vesicles. 2018;7(1):1422674. Available from: https://www.tandfonline.com/doi/full/10.1080/20013078.2017.1422674
- Laner-Plamberger S, Lener T, Schmid D, et al. Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate. J Transl Med. 2015;13(1):354. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26554451
- Watson DC, Yung BC, Bergamaschi C, et al. Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes. J Extracell Vesicles. 2018;7(1):1442088. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29535850
- Wei Z, Batagov AO, Carter DRF, et al. Fetal bovine serum RNA interferes with the cell culture derived extracellular RNA. Sci Rep. 2016;6:31175. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27503761
- Liao Z, Muth DC, Eitan E, et al. Serum extracellular vesicle depletion processes affect release and infectivity of HIV-1 in culture. Sci Rep. 2017;7(1):2558.
- Gardiner C, Di Vizio D, Sahoo S, et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell Vesicles. 2016;5:32945. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27802845
- Webber J, Clayton A. How pure are your vesicles? J Extracell Vesicles. 2013;2:19861. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24009896
- Linares R, Tan S, Gounou C, et al. High-speed centrifugation induces aggregation of extracellular vesicles. J Extracell Vesicles. 2015;4(1):29509. Available from: https://www.tandfonline.com/doi/full/10.3402/jev.v4.29509
- Ludwig A-K, De Miroschedji K, Doeppner TR, et al. Precipitation with polyethylene glycol followed by washing and pelleting by ultracentrifugation enriches extracellular vesicles from tissue culture supernatants in small and large scales. J Extracell Vesicles. 2018;7(1):1528109. Available from: https://www.tandfonline.com/doi/full/10.1080/20013078.2018.1528109
- Gimona M, Pachler K, Laner-Plamberger S, et al. Manufacturing of human extracellular vesicle-based therapeutics for clinical use. Int J Mol Sci. 2017;18(6):1190. Available from: http://www.mdpi.com/1422-0067/18/6/1190
- Li P, Kaslan M, Lee SH, et al. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789–804. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28255367
- Willis GR, Kourembanas S, Mitsialis SA. Toward exosome-based therapeutics: isolation, heterogeneity, and fit-for-purpose potency. Front Cardiovasc Med. 2017;4:63. Available from: http://journal.frontiersin.org/article/10.3389/fcvm.2017.00063/full
- Busatto S, Vilanilam G, Ticer T, et al. Tangential flow filtration for highly efficient concentration of extracellular vesicles from large volumes of fluid. Cells. 2018;7(12):273. Available from: http://www.mdpi.com/2073-4409/7/12/273
- Görgens A, Bremer M, Ferrer-Tur R, et al. Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material. 2019. DOI:10.1080/2001307820191587567
- van Balkom BW, Gremmels H, Giebel B, et al. Proteomic signature of mesenchymal stromal cell-derived small extracellular vesicles. Proteomics. 2018;1800163. DOI:10.1002/pmic.201800163
- Giebel B, Helmbrecht C. Methods to Analyze EVs. Methods Mol Biol. 2017;1545:1–20.
- Anderson W, Kozak D, Coleman VA, et al. A comparative study of submicron particle sizing platforms: accuracy, precision and resolution analysis of polydisperse particle size distributions. J Colloid Interface Sci. 2013;405:322–330. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23759321
- Gardiner C, Ferreira YJ, Dragovic RA, et al. Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracell Vesicles. 2013;2:19671.
- Dragovic RA, Gardiner C, Brooks AS, et al. Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis. Nanomedicine. 2011 May 24;7(6):780–788. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21601655
- Sokolova V, Ludwig AK, Hornung S, et al. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces. 2011 Jun 07;87(1):146–150. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21640565
- Lai RC, Lim SK. Membrane lipids define small extracellular vesicle subtypes secreted by mesenchymal stromal cell. J Lipid Res. 2018;jlr.R087411. Available from: http://www.jlr.org/lookup/doi/10.1194/jlr.R087411
- Laulagnier K, Motta C, Hamdi S, et al. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem J. 2004;380(Pt 1):161–171.
- Llorente A, Skotland T, Sylvänne T, et al. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim Biophys Acta. 2013;1831(7):1302–1309. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24046871
- Webinar GA. Analysis of extracellular vesicles including exosomes by imaging flow cytometry. Science (80-). 2016;352(6290):1238.2–1238. Available from: http://www.sciencemag.org/lookup/doi/10.1126/science.352.6290.1238-b
- Scherr SM, Daaboul GG, Trueb J, et al. Real-time capture and visualization of individual viruses in complex media. ACS Nano. 2016;10(2):2827–2833.
- Tian Y, Ma L, Gong M, et al. Protein profiling and sizing of extracellular vesicles from colorectal cancer patients via flow cytometry. ACS Nano. 2018;12(1):671–680. Available from: http://pubs.acs.org/doi/10.1021/acsnano.7b07782
- Clayton A, Buschmann D, Byrd JB, et al. Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017. J Extracell Vesicles. 2018;7(1):1473707. Available from: https://www.tandfonline.com/doi/full/10.1080/20013078.2018.1473707
- Tan SS, Yin Y, Lee T, et al. Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane. J Extracell Vesicles. 2013;2.
- Arslan F, Lai RC, Smeets MB, et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 2013;10(3):301–312.
- Mateescu B, Kowal EJK, Bwm VB, et al. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA – an ISEV position paper. J Extracell Vesicles. 2017;(6(1))1286095. Available from: https://www.tandfonline.com/doi/full/10.1080/20013078.2017.1286095
- Martinez J, Patkaniowska A, Urlaub H, et al. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell. 2002;110(5):563–574. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12230974